Inhibition of -type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment
Unlike normal cells, cancer cells undergo unlimited growth and multiplication, causing them to require massive amounts of amino acid to support their continuous metabolism. Among the amino acid transporters expressed on the plasma membrane, l- type amino acid transporter-1, a Na + - independent neut...
Main Authors: | Supak Yothaisong, Hasaya Dokduang, Naohiko Anzai, Keitaro Hayashi, Nisana Namwat, Puangrat Yongvanit, Sakkarn Sangkhamanon, Promsuk Jutabha, Hitoshi Endou, Watcharin Loilome |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-02-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317694545 |
Similar Items
-
LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells
by: Keitaro Hayashi, et al.
Published: (2016-11-01) -
LAT1 Is a Central Transporter of Essential Amino Acids in Human Umbilical Vein Endothelial Cells
by: Keitaro Hayashi, et al.
Published: (2014-01-01) -
Molecular Mechanism of Ochratoxin A Transport in the Kidney
by: Naohiko Anzai, et al.
Published: (2010-06-01) -
Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool
by: Wassana Jamnongkan, et al.
Published: (2017-07-01) -
Mechanisms of oxysterol-induced carcinogenesis
by: Loilome Watcharin, et al.
Published: (2011-03-01)